Aprea Therapeutics, Inc. Public Float
Aprea Therapeutics, Inc. (APRE) had Public Float of $8.60 million as of 2025-06-30, per its 10-K filed 2026-03-16.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-16
- 2025-06-30: Entity Public Float $8.60M.
- 2024-06-28: Entity Public Float $10.00M.
- 2023-06-30: Entity Public Float $10.00M.
- 2022-06-30: Entity Public Float $14.00M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $8.60M 10-K · filed 2026-03-16 |
| 2024-06-28 | $10.00M 10-K · filed 2025-03-25 |
| 2023-06-30 | $10.00M 10-K · filed 2024-03-26 |
| 2022-06-30 | $14.00M 10-K/A · filed 2023-04-28 |
| 2021-06-30 | $70.40M 10-K/A · filed 2022-05-02 |
| 2020-06-30 | $263.80M 10-K · filed 2021-03-16 |
| 2019-06-28 | $0.00 10-K · filed 2020-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |